Evidence map›Paper›PMID 31495071›Full record

ArticleFEBS open bio2019

5-ALA/SFC enhances HO-1 expression through the MAPK/Nrf2 antioxidant pathway and attenuates murine tubular epithelial cell apoptosis.

Chi Liu, Masayuki Fujino, Shuoji Zhu, Yoshitaka Isaka, Hidenori Ito, Kiwamu Takahashi, Motowo Nakajima, Tohru Tanaka, Ping Zhu, Xiao-Kang Li

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Chi LiuDivision of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
Masayuki FujinoDivision of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
Shuoji ZhuGuangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, China.
Yoshitaka IsakaDepartment of Nephrology, Osaka University Graduate School of Medicine, Japan.
Hidenori ItoSBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Kiwamu TakahashiSBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Motowo NakajimaSBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Tohru TanakaSBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Ping ZhuGuangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, China.
Xiao-Kang LiDivision of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.ORCID 0000-0002-0897-2141
SBI Pharmaceuticals (Japan) · JPGuangdong Academy of Medical Sciences · CNNational Center For Child Health and Development · JPNational Institute of Infectious Diseases · JPOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclosporin A (CsA) is a common immunosuppressant, but its use is limited as it can cause chronic kidney injury. Oxidative stress and apoptosis play a key role in CsA-induced nephrotoxicity. This study investigated the protective effect of 5-aminolevulinic acid and iron (5-ALA/SFC) on CsA-induced injury in murine proximal tubular epithelial cells (mProx24). 5-ALA/SFC significantly inhibited apoptosis in CsA-treated mProx24 cells with increases in heme oxygenase (HO)-1, nuclear factor E2-related factor 2 (Nrf2), and p38, and Erk-1/2 phosphorylation. Moreover, 5-ALA/SFC suppressed production of reactive oxygen species in CsA-exposed cells and inhibition of HO-1 suppressed the protective effects of 5-ALA/SFC. In summary, 5-ALA/SFC may have potential for development into a treatment for the anti-nephrotoxic/apoptotic effects of CsA.

Indexed as

Aminolevulinic AcidAnimalsAntioxidantsApoptosisCells, CulturedCitric AcidEpithelial CellsFerrous CompoundsHeme Oxygenase-1Kidney TubulesLevulinic AcidsMiceMitogen-Activated Protein KinasesNF-E2-Related Factor 2Aminolevulinic AcidAntioxidantsCitric Acidferrous citrateFerrous CompoundsHeme Oxygenase-1Levulinic AcidsMitogen-Activated Protein KinasesNF-E2-Related Factor 25-aminolevulinic acidapoptosisCyclosporine Aheme oxygenase-1oxidative stress

Identifiers

PMID31495071
PMCPMC6823284
OpenAlexW2972348610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.